Skip to Content

DaVita Inc DVA Stock Quote

| Rating as of


Market Closed

| Currency in USD

  • Last Close 96.30
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Investment Style Mid Blend
  • Day Range 94.57  –  96.47
  • Year Range 65.28  –  116.97
  • Market Cap 8.7922 Bil
  • Volume / Avg 524,582.0 /  687,707.8
  • Price / Sales 0.76
  • Price / Book 8.64
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis DVA

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


DaVita Emerging From Weak Pandemic Years

Julie Utterback Senior Equity Analyst

Business Strategy and Outlook

| Julie Utterback |

After selling the DaVita Medical Group in 2019, DaVita focuses almost exclusively on providing services to end-stage renal disease, or ESRD, patients primarily in the United States with an expanding international footprint. Over several decades, DaVita has built the largest network of dialysis clinics in the U.S., and although COVID-19-related mortality and labor pressures cut into DaVita's profits in recent years, we view DaVita's long-term prospects as solid.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics DVA

Company Profile DVA

Business Description

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

2000 16th Street
Denver, CO, 80202
Industry Medical Care Facilities
Employees 70,000

Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of DVA’s competitive advantage.

DaVita Inc


Tenet Healthcare Corp


Fresenius Medical Care AG & Co. KGaA


HCA Healthcare Inc

+$0.56 (0.58%) +$1.19 (1.80%) −$0.23 (0.56%) +$3.39 (1.37%)
Market Cap
8.79 Bil6.84 Bil12.03 Bil68.17 Bil
Medical Care Facilities Medical Care Facilities Medical Care Facilities Medical Care Facilities

* Trading data in this section is delayed by at least 15 minutes.

FAQs for DaVita Inc Stock

No. DVA does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

DVA’s market cap is 8.79 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

DVA’s stock style is Mid Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

DVA’s price/sales is 0.76.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

DVA’s price/forward earnings is 19.69.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

DVA’s price/book is 8.64.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See DVA’s valuation ratios compared to the Market Index.

DVA’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare DVA’s historical performance against its industry peers and the overall market.